AGTC

FILL THE SHORT

ID	stock	broker	amount	AVG	BUY TOTAL	date	time	Filled price	amount filled	volume	Total filled	total Stock	Total $	final price	Remark
15	AGTC	RH	50	$3.09	$154.50	7/29/2022		$0.38	5,000.00	0	$1,875.00	5050	$2,029.50	$0.40

 

ID	stock	broker	amount	AVG	BUY TOTAL	date	time	Filled price	amount filled	volume	Total filled	total Stock	Total $	final price	Remark
15	AGTC	RH	50	$3.09	$154.50	7/29/2022		$0.38	1,000.00	0	$375.00	1050	$529.50	$0.50

ID	stock	broker	amount	AVG	BUY TOTAL	date	time	Filled price	amount filled	volume	Total filled	total Stock	Total $	final price	Remark
15	AGTC	RH	50	$3.09	$154.50	7/29/2022		$0.38	500.00	0	$187.50	550	$342.00	$0.62

Applied Genetic Technologies Corp. is a clinical stage biotechnology company, which engages in the development of a gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. It has clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL. The listed name for AGTC is Applied Genetic Technologies Corporation Common Stock.